1. Introduction {#sec1-ijms-16-25993}
===============

*Platycodon grandiflorum*, a perennial herb grown widely in Northeast Asia, contains triterpenoid saponins, carbohydrates, fibers, *etc.* \[[@B1-ijms-16-25993],[@B2-ijms-16-25993]\]. *P. grandiflorum* has been used as a food material and a traditional medicine. *Platycodin radix*, the root of *P. grandiflorum*, has various benefits for health, and its biological usefulness has been reviewed \[[@B3-ijms-16-25993]\]. Interest in platycodin saponins, the main components of *P. grandiflorum*, has increased recently due to their novel pharmacological activities, including anti-inflammatory, anti-oxidant, anti-lipidemic, anti-obesity, anti-cancer activities and their ability to improve insulin resistance \[[@B4-ijms-16-25993],[@B5-ijms-16-25993],[@B6-ijms-16-25993],[@B7-ijms-16-25993],[@B8-ijms-16-25993],[@B9-ijms-16-25993],[@B10-ijms-16-25993],[@B11-ijms-16-25993]\]. Furthermore, in a previous study, various components were isolated from the flower of *P. grandiflorum*, and their biological activities were monitored \[[@B12-ijms-16-25993]\]. Thus, it is critical to study not only *Platycodin radix*, but also different parts of *P. grandiflorum* in order to screen it for useful components.

Recently, metabolomics approaches have been used to assess the metabolite contents of individual plant species \[[@B13-ijms-16-25993]\]. For plant metabolomics, well-constructed analytical platforms are necessary \[[@B14-ijms-16-25993],[@B15-ijms-16-25993]\]. Nuclear magnetic resonance spectroscopy and gas chromatography or liquid chromatography (LC) coupled with mass spectrometry (MS) have been widely used to analyze plant metabolites \[[@B16-ijms-16-25993],[@B17-ijms-16-25993],[@B18-ijms-16-25993],[@B19-ijms-16-25993],[@B20-ijms-16-25993]\]. In particular, metabolite profiling by LC/MS is applicable to phenotype and can discriminate individual plant species \[[@B21-ijms-16-25993],[@B22-ijms-16-25993],[@B23-ijms-16-25993]\]. In this study, we constructed a profiling method based on LC/MS to analyze the metabolites of *P. grandiflorum*. Metabolite extraction protocols and LC/MS conditions were optimized to profile two different parts ((1) *P. grandiflorum* roots (PR) and (2) *P. grandiflorum* stems and leaves (PS)).

2. Results and Discussion {#sec2-ijms-16-25993}
=========================

2.1. Construction of LC-MS Conditions to Profile Platycodon grandiflorum Metabolites {#sec2dot1-ijms-16-25993}
------------------------------------------------------------------------------------

For the high-throughput and sensitive analysis of various metabolites in *P. grandiflorum*, it is necessary to construct a robust method of profiling. The UPLC system with its small particle size column enables the fast and effective separation of various molecules. Furthermore, QTOF/MS is a good tool for a full mass scan with high resolution. Thus, in this study, UPLC-QTOF/MS was applied to profile *P. grandiflorum* metabolites. First, we used seven standards (*i.e.*, platycoside E, platycodin D3, platycodin D2, platycodin D, polygalacin D, platycogenic acid A and platycodigenin) to optimize the LC-MS conditions. In the negative mode of electrospray ionization (ESI), seven compounds were mainly detected as \[M − H\]^−^ and \[M + COOH\]^−^ ions ([Table 1](#ijms-16-25993-t001){ref-type="table"}). These standards were separated well and eluted for 15 min ([Figure 1](#ijms-16-25993-f001){ref-type="fig"}) at a flow rate of 450 µL/min by using an ACQUITY BEH C18 column (2.1 mm × 100 mm, 1.7 µm particle size). Second, two extracts of PR and PS were analyzed in both positive and negative ion modes. As a result, chromatographic data from the positive mode showed poor efficiency of ionization (data not shown). Thus, we carried out the profiling of PR and PS in the negative mode only. Various metabolites of PR and PS were also separated well in 15 min ([Figure 1](#ijms-16-25993-f001){ref-type="fig"}). The gradient elution program consisted of a first linear gradient from steady (A/B: 90/10) to solvent (A/B: 80/20) for 3 min; followed by a second linear gradient to solvent (A/B: 77/23) for 8 min; a third linear gradient to solvent (A/B: 5/95) for 9 min; and a forth linear gradient to solvent (A/B: 90/10) for 1 min. The column was equilibrated at 10% Solvent B for 4 min before reuse. The total run time was 25 min for each analysis. Third, we validated the performance of the *P. grandiflorum* metabolites' profiling method. For this, we drew the standard curves of seven standards and calculated their linearity range and correlation. The limits of detection (LODs) of each isolated compound are also listed ([Table 2](#ijms-16-25993-t002){ref-type="table"}).

ijms-16-25993-t001_Table 1

###### 

List of seven standards analyzed by UPLC-QTOF/MS. RT, retention time.

  No.   Standards             RT (min)   Molecular Formula   Expected Neutral Mass (Da)   Observed Neutral Mass (Da)   QTOF/MS (ESI-) *m/z*   Mass Accuracy (ppm)   Adducts
  ----- --------------------- ---------- ------------------- ---------------------------- ---------------------------- ---------------------- --------------------- ---------
  1     Platycoside E         4.01       C~69~H~112~O~38~    1548.6832                    1548.6783                    1593.6765              −3.08                 +HCOO
  2     Platycodin D3         5.43       C~63~H~102~O~33~    1386.6303                    1386.6268                    1431.625               −2.44                 +HCOO
  3     Platycodin D2         9.04       C~63~H~102~O~33~    1386.6303                    1386.6264                    1385.6191              −2.84                 -H
  4     Platycodin D          9.18       C~57~H~92~O~28~     1224.5775                    1224.5765                    1269.5747              −0.82                 +HCOO
  5     Polygalacin D         9.82       C~57~H~92~O~27~     1208.5826                    1208.5795                    1253.5777              −2.5                  +HCOO
  6     Platycogenic acid A   10.36      C~57~H~90~O~29~     1238.5568                    1238.5562                    1237.5489              −0.5                  -H
  7     Platycodigenin        13.85      C~30~H~48~O~7~      520.34                       520.3399                     519.3326               −0.21                 -H

ijms-16-25993-t002_Table 2

###### 

The linearity range, correlation (*R^2^*) and LOD of seven standards by UPLC-QTOF/MS.

  No.   Standards             Correlation (*R*^2^)   Linear Range (ng)   LOD (ng)
  ----- --------------------- ---------------------- ------------------- ----------
  1     Platycoside E         0.9939                 1--40               1
  2     Platycodin D3         0.9975                 1--100              1
  3     Platycodin D2         0.9976                 1--100              1
  4     Platycodin D          0.9898                 1--40               1
  5     Polygalacin D         0.9926                 0.2--100            0.2
  6     Platycogenic acid A   0.9957                 1--100              1
  7     Platycodigenin        0.9952                 0.2--20             0.2

![UPLC-QTOF/MS, ESI- base peak intensity (BPI) chromatogram of (**A**) *P. grandiflorum* roots; (**B**) *P. grandiflorum* stems and leaves and (**C**) seven standards, including (1) platycoside E, (2) platycodin D3, (3) platycodin D2, (4) platycodin D, (5) polygalacin D, (6) platycogenic acid A and (7) platycodigenin.](ijms-16-25993-g001){#ijms-16-25993-f001}

2.2. Optimization of Extraction Protocols for Platycodon grandiflorum Metabolites {#sec2dot2-ijms-16-25993}
---------------------------------------------------------------------------------

Next, we optimized the protocols to extract metabolites, including various isolated compounds from two different parts (PR and PS). There are several factors involved in the optimization of extraction protocols. First, it is critical to select suitable solvents for the extraction of various metabolites with different polarities. A single solvent is insufficient to dissolve the wide range of compounds, and several solvents, such as water, ethanol (EtOH) and methanol (MeOH), have been widely used to extract plant metabolites. To find the most effective solvent for extraction, we tried to compare six different solvents (50% EtOH, 70% EtOH, 80% EtOH, 50% MeOH, 70% MeOH and 80% MeOH) while other factors, such as solvent amount (20 mL) and sonication time (30 min), were kept constant. As a result, 70% EtOH exhibited the largest number of peaks and the highest intensity of several compounds. Second, the ratio of solvent to sample is also a critical factor in the metabolites' extraction due to the limited solubility of samples. Thus, we compared four different amounts (10, 20, 30 and 40 mL) of solvent, 70% EtOH, to extract metabolites from the 50 mg of samples while the sonication time (30 min) was kept constant. Among them, 40 mL provided the largest amount of extracts. Third, different sonication times (15, 30, 45, 60 and 75 min) were tested in the use of 40 mL of 70% EtOH, and as a result, it was found that at least 60 min of sonication were required to extract many metabolites. Finally, we optimized the solvent used (70% EtOH), the ratio of solvent to sample (40 mL:50 mg) and the sonication time (60 min) for the effective extraction of metabolites from *P. grandiflorum*.

2.3. Analysis of Various Metabolites in the Stem, Leaf and Roots of *Platycodon grandiflorum* {#sec2dot3-ijms-16-25993}
---------------------------------------------------------------------------------------------

We applied the proposed method based on UPLC-QTOF/MS to profile various metabolites in PR and PS. Three species of *P. grandiflorum* were used to obtain three PRs and three PSs. We extracted the metabolites from the three PRs and three PSs, respectively, analyzed each extract three times (*n* = 3) and then processed each set of data using the UNIFI^TM^ software (Version 1.7.1; Waters Corp.). As a result, various metabolites, including several platycosides, were identified based on the library of UNIFI software containing information for the molecule's name and formula \[[@B24-ijms-16-25993]\]. From the processed data, compounds identified repeatedly (*n* = 3) having high mass accuracy (ppm \< ±5) are listed in [Table 3](#ijms-16-25993-t003){ref-type="table"} and [Table 4](#ijms-16-25993-t004){ref-type="table"}, respectively. In the peak assignment, it is critical to estimate retention time (RT) (RT tolerance: 0.2 min) and mass accuracy. In the samples of PR and PS, four compounds, such as platycoside E, platycodin D, platycodin D2 and platycodin D3, were analyzed with small RT shifts compared to the standard analysis. We also describe the Venn diagram of metabolites analyzed in three PRs and three PSs to show how the metabolic compositions of each plant species (PR-1, -2 and -3 or PS-1, -2 and -3) were different ([Figure 2](#ijms-16-25993-f002){ref-type="fig"}). Two parts of *P. grandiflorum* (PR and PS) showed qualitatively and quantitatively different metabolite profiles. Furthermore, the metabolite profiles differed according to individual samples. In particular, several platycosides were abundantly different in the three PRs and three PSs, respectively ([Figure 3](#ijms-16-25993-f003){ref-type="fig"}). For example, comparing to other PR species, PR-1 has 1.5-times more abundant platycodin D3, and PR-2 has two-times less abundant platycodin A. Compared to other PS species, PS-3 also has 2.5-times more abundant platycodin A.

![Venn diagram of metabolites analyzed in three *P. grandiflorum* roots (PRs) and three *P. grandiflorum* stems and leaves (PSs) (ESI-).](ijms-16-25993-g002){#ijms-16-25993-f002}

ijms-16-25993-t003_Table 3

###### 

List of metabolites analyzed in *P. grandiflorum* root (ESI-).

  No.   RT (min)   Metabolites                    Expected Neutral Mass (Da)   Observed Neutral Mass (Da)   QTOF/MS (ESI-) *m/z*   Mass Accuracy (ppm)   Adducts   Intensity (*n* = 3)                   
  ----- ---------- ------------------------------ ---------------------------- ---------------------------- ---------------------- --------------------- --------- --------------------- --------------- ---------------
  1     0.55       Glutamine                      146.0691                     146.0688                     145.0615               −2.5                  -H        ^a^ 1837 ± 187        \-              \-
  2     0.55       Planteose                      504.169                      504.169                      549.1672               0                     +HCOO     4903 ± 667            \-              5636 ± 392
  3     0.55       α-Kojibiose                    342.1162                     342.1161                     387.1143               −0.22                 -H        1837 ± 958            16,344 ± 1310   \-
  4     0.6        Maleic acid                    116.011                      116.0113                     115.004                2.98                  -H        \-                    487 ± 66        483 ± 31
  5     0.62       2-Hydroxyfuran-3-formic acid   128.011                      128.0104                     173.0086               −3.5                  +HCOO     2305 ± 106            2025 ± 113      1752 ± 44
  6     0.63       2-Furoic acid                  112.016                      112.0163                     111.009                1.99                  -H        7646 ± 355            6875 ± 226      5943 ± 171
  7     0.63       Citric acid                    192.027                      192.0264                     191.0191               −3.21                 -H        41,368 ± 2527         37,122 ± 1795   32,419 ± 1422
  8     2.11       Arnebifuranone                 316.1311                     316.1310                     361.1292               −0.19                 +HCOO     661 ± 20              889 ± 28        656 ± 31
  9     2.35       Brusatol                       520.1945                     520.1934                     565.1917               −1.8                  +HCOO     4005 ± 351            2836 ± 266      5753 ± 492
  10    3.8        Platycoside G1                 1416.6409                    1416.6364                    1461.6346              −3.11                 +HCOO     2456 ± 195            2457 ± 100      5734 ± 106
  11    3.97       Platycoside E                  1548.6832                    1548.6788                    1593.677               −2.74                 +HCOO     4451 ± 655            8863 ± 674      9183 ± 699
  12    3.99       Lobetyolin                     396.1784                     396.1785                     441.1767               0.19                  +HCOO     13,407 ± 265          5473 ± 271      6794 ± 393
  13    4.15       Platycoside D                  1532.6882                    1532.679                     1577.6772              −5.83                 +HCOO     \-                    385 ± 47        500 ± 30
  14    4.98       Platycoside A                  1254.5881                    1254.5849                    1299.5831              −2.48                 +HCOO     13,802 ± 805          6425 ± 435      10,745 ± 864
  15    5.31       Platycodin D3                  1386.6303                    1386.6261                    1431.6243              −2.96                 +HCOO     40,086 ± 4797         25,927 ± 2368   24,630 ± 2328
  16    5.67       Platycoside G2                 1284.5986                    1284.5937                    1283.5865              −3.82                 -H        1626 ± 140            926 ± 103       1503 ± 149
  17    8.24       Deapioplatycodin D             1092.5353                    1092.5333                    1137.5315              −1.74                 +HCOO     658 ± 47              \-              443 ± 45
  18    8.8        Platycodin D2                  1386.6303                    1386.6231                    1385.6159              −5.2                  -H        3130 ± 171            744 ± 44        1172 ± 103
  19    8.93       Platycodin D                   1224.5775                    1224.5717                    1269.5699              −4.58                 +HCOO     ^a^ 4868 ± 606        1255 ± 67       1757 ± 161
  20    9.35       Platycodin A                   1266.5881                    1266.5844                    1311.5826              −2.82                 +HCOO     27,391 ± 2780         12,819 ± 889    24,750 ± 2250

^a^ The values are the mean of intensities ±SD (*n* = 3).

ijms-16-25993-t004_Table 4

###### 

List of metabolites analyzed in *P. grandiflorum* stems and leaves (ESI-).

  No.   RT (min)   Metabolites                                                            Expected Neutral Mass (Da)   Observed Neutral Mass (Da)   QTOF/MS (ESI-) *m/z*   Mass Accuracy (ppm)   Adducts   Intensity (*n* = 3)                    
  ----- ---------- ---------------------------------------------------------------------- ---------------------------- ---------------------------- ---------------------- --------------------- --------- --------------------- ---------------- ----------------
  1     0.51       Arginine                                                               174.1117                     174.1114                     173.1041               −1.65                 -H        ^a^ 477 ± 38          594 ± 37         \-
  2     0.55       Aspartic acid                                                          133.0375                     133.0374                     132.0301               −0.79                 -H        405 ± 53              \-               \-
  3     0.55       Glutamic acid                                                          147.0532                     147.0529                     146.0456               −1.59                 -H        464 ± 47              506 ± 30         \-
  4     0.55       Glutamine                                                              146.0691                     146.0692                     145.0619               0.14                  -H        1306 ± 223            2516 ± 304       \-
  5     0.55       Planteose                                                              504.169                      504.1687                     549.1669               −0.57                 +HCOO     619 ± 59              \-               \-
  6     0.55       Sodium ferulate                                                        216.0399                     216.0391                     215.0318               −3.58                 -H        996 ± 77              \-               924 ± 36
  7     0.55       α-Kojibiose                                                            342.1162                     342.1162                     387.1144               −0.03                 +HCOO     \-                    \-               10,644 ± 1655
  8     0.56       Ribose                                                                 150.0528                     150.0522                     195.0504               −3.26                 +HCOO     1321 ± 83             1488 ± 103       1994 ± 138
  9     0.6        Maleic acid                                                            116.011                      116.0113                     115.004                2.99                  -H        2127 ± 103            2421 ± 125       1743 ± 58
  10    0.61       5-Oxoproline                                                           129.0426                     129.0427                     128.0354               0.88                  -H        \-                    643 ± 49         \-
  11    0.61       Pyruvic acid                                                           88.016                       88.0161                      133.0143               0.3                   +HCOO     10,969 ± 482          11,961 ± 423     8726 ± 469
  12    0.62       2-Furoic acid                                                          112.016                      112.0164                     111.0091               3.1                   -H        4606 ± 239            5134 ± 222       3194 ± 252
  13    0.62       2-Hydroxyfuran-3-formic acid                                           128.011                      128.0106                     173.0088               −2.23                 +HCOO     ^a^ 1611 ± 92         1806 ± 111       1397 ± 60
  14    0.62       Citric acid                                                            192.027                      192.0263                     191.019                −3.61                 -H        26,784 ± 677          30,360 ± 1294    18,681 ± 375
  15    0.77       6,7-Dihydroxycoumarin                                                  178.0266                     178.0261                     223.0243               −2.23                 +HCOO     1090 ± 83             677 ± 33         513 ± 27
  16    0.8        1-*O*-Caffeoyquinic acid                                               354.0951                     354.0951                     353.0878               0.05                  -H        \-                    \-               4272 ± 498
  17    1          Decaffeoylacteoside                                                    462.1737                     462.1741                     461.1669               0.91                  -H        339 ± 46              494 ± 50         329 ± 33
  18    1.01       Tryptophan                                                             204.0899                     204.0899                     203.0826               −0.01                 -H        813 ± 83              974 ± 106        566 ± 34
  19    1.06       Quinic acid                                                            192.0634                     192.063                      191.0557               −2.21                 -H        26,641 ± 1875         27,777 ± 2173    31,286 ± 1747
  20    1.07       4-*O*-Caffeoylquinic acid                                              354.0951                     354.0951                     353.0878               −0.08                 -H        \-                    \-               83,405 ± 3981
  21    1.1        Shikimic acid                                                          174.0528                     174.0527                     173.0454               −0.78                 -H        591 ± 50              624 ± 77         811 ± 90
  22    1.15       1,5-Dihydrxy-2,3,4,7-tetramethoxyxanthone                              348.0845                     348.0838                     393.082                −1.77                 +HCOO     354 ± 20              \-               329 ± 25
  23    1.15       4-*O*-β-[d]{.smallcaps} Glucopyranosyl-cis-cinnamic acid               326.1002                     326.1002                     325.0929               0.08                  -H        1445 ± 147            \-               1392 ± 86
  24    1.21       Genistein-7,4\'-di-*O*-β-[d]{.smallcaps}-glucoside                     594.1585                     594.1583                     593.151                −0.32                 -H        \-                    1280 ± 176       \-
  25    1.26       1-*~O~*-Caffeoyl-β-[d]{.smallcaps}-glucopyranoside                     342.0951                     342.095                      341.0878               −0.14                 -H        2243 ± 143            2603 ± 289       2525 ± 148
  26    1.35       *o*-Coumaric acid                                                      164.0473                     164.0472                     163.04                 −0.6                  -H        670 ± 118             859 ± 177        962 ± 102
  27    1.38       Chlorogenic acid                                                       354.0951                     354.095                      353.0877               −0.27                 -H        12,530 ± 967          14,301 ± 1076    14,725 ± 798
  28    1.91       3-*O*-trans-Coumaroylquinic acid                                       338.1002                     338.1001                     337.0928               −0.24                 -H        3879 ± 282            6685 ± 483       3502 ± 257
  29    2.04       9-Hydroxylinalool-9-β-[d]{.smallcaps}-glucopyranoside                  332.1835                     332.1834                     377.1816               −0.35                 +HCOO     680 ± 116             431 ± 77         868 ± 111
  30    2.11       Arnebifuranone                                                         316.1311                     316.131                      361.1292               −0.1                  +HCOO     \-                    373 ± 32         \-
  31    2.24       Kaempferol-3-*O*-neohesperidoside                                      594.1585                     594.1581                     593.1508               −0.69                 -H        \-                    \-               ^a^ 1578 ± 158
  32    2.37       Brusatol                                                               520.1945                     520.1944                     565.1926               −0.08                 +HCOO     \-                    6136 ± 483       4755 ± 461
  33    2.4        Kaempferol-3-gentiobioside                                             610.1534                     610.1523                     609.145                −1.86                 -H        \-                    1030 ± 284       \-
  34    2.49       Kaempferol                                                             286.0477                     286.0467                     285.0394               −3.62                 -H        \-                    \-               4400 ± 366
  35    2.5        Quercetin-3-*O*-glucuronide 6″-methyl ester                            492.0904                     492.0907                     491.0834               0.58                  -H        1028 ± 88             900 ± 100        \-
  36    2.53       Taraxacolide 1-glucopyranoside                                         430.2203                     430.2204                     475.2186               0.3                   +HCOO     3078 ± 242            4529 ± 519       3659 ± 430
  37    3          1,5-*O*-Dicaffeoylquinic acid                                          516.1268                     516.1269                     515.1196               0.25                  -H        \-                    \-               510 ± 31
  38    3.27       3\'-Hydroxypuerarin                                                    448.1006                     448.1009                     447.0936               0.75                  -H        1894 ± 208            2107 ± 231       2228 ± 243
  39    3.27       Eriodictyol-7-*O*-β-[d]{.smallcaps}-methyl-glucuronopyranoside         478.1111                     478.111                      477.1038               −0.19                 -H        \-                    750 ± 67         975 ± 61
  40    3.37       Luteolin 7-*O*-(6\'\'- *O*-acetyl)-β-[d]{.smallcaps}-glucopyranoside   490.1111                     490.1112                     489.1039               0.13                  -H        790 ± 58              21,846 ± 1788    7148 ± 472
  41    3.37       Quercetin-3-*O*-(6\"-*O*-acetyl)-β-[d]{.smallcaps}-glucopyranoside     506.106                      506.107                      505.0997               1.91                  -H        \-                    369 ± 34         763 ± 116
  42    3.38       Epicatechin-3-*O*-gallate                                              442.09                       442.0907                     487.0889               1.49                  +HCOO     \-                    3838 ± 400       1207 ± 95
  43    3.58       5-*O*-Caffeoyl quinic acid butyl ester                                 410.1577                     410.1579                     409.1506               0.5                   -H        328 ± 28              516 ± 96         361 ± 21
  44    3.62       Kaempferol-3-*O*-(6′′-*O*-acetyl)-β-[d]{.smallcaps}-glucopyranoside    490.1111                     490.1122                     489.1049               2.14                  -H        74,782 ± 6202         \-               \-
  45    3.99       Methyl-β-[d]{.smallcaps}-fructofuranoside                              180.0634                     180.0632                     179.0559               −0.9                  -H        1944 ± 224            2168 ± 222       \-
  46    4.98       Platycoside A                                                          1254.588                     1254.585                     1299.583               −2.28                 +HCOO     417 ± 48              815 ± 147        1088 ± 108
  47    5.11       5,7,3′,5′-Tetrahydroxyflavanone                                        288.0634                     288.0629                     287.0556               −1.81                 -H        3719 ± 239            2445 ± 142       \-
  48    5.24       Epigallocatechin                                                       594.1373                     594.137                      593.1298               −0.49                 -H        \-                    \-               581 ± 78
  49    5.31       Platycodin D3                                                          1386.63                      1386.625                     1431.623               −3.83                 +HCOO     ^a^ 1582 ± 209        3569 ± 375       3396 ± 291
  50    5.35       5,7,2\',5\'-Tetrahydroxy-flavone                                       286.0477                     286.0473                     285.04                 −1.48                 -H        152,282 ± 7073        146,318 ± 5227   136,503 ± 4826
  51    5.36       5,7,8,3′,4′-Pentamethoxy flavones                                      302.0427                     302.0424                     301.0352               −0.71                 -H        542 ± 63              558 ± 76         515 ± 45
  52    6.27       Apigenin-7-*O*-β-[d]{.smallcaps}-glucuronide ethyl ester               474.1162                     474.1166                     473.1093               0.79                  -H        2009 ± 109            1265 ± 145       \-
  53    7.83       Apigenol                                                               270.0528                     270.0522                     269.0449               −2.32                 -H        43,135 ± 2315         59,953 ± 3044    38,068 ± 1691
  54    8.8        Platycodin D2                                                          1386.63                      1386.626                     1385.618               −3.45                 -H        849 ± 156             792 ± 113        1307 ±205
  55    8.94       Platycodin D                                                           1224.578                     1224.574                     1269.572               −2.86                 +HCOO     613 ± 88              763 ± 87         1416 ± 190
  56    9.37       Platycodin A                                                           1266.588                     1266.584                     1311.583               −2.91                 +HCOO     8564 ± 832            8149 ± 769       21,255 ± 1202

^a^ The values are the mean of intensities ±SD (*n* = 3).

![Bar graph of several platycosides in three PRs (**A**) and three PSs (**B**).](ijms-16-25993-g003){#ijms-16-25993-f003}

3. Experimental Section {#sec3-ijms-16-25993}
=======================

3.1. Platycodon grandiflorum Samples {#sec3dot1-ijms-16-25993}
------------------------------------

The samples of *Platycodon grandiflorum* (roots, stems and leaves) were purchased from a Daegu Herbal Market in Daegu Gyeongbuk Province, Korea, in 2014. Voucher specimen (NIHHS150128) was deposited at the herbarium of the Department of Herbal Crop Research, National Institute of Horticultural and Herbal Science, Rural Development Administration, Eumseong, Korea.

3.2. Standard Constituents and Reagents {#sec3dot2-ijms-16-25993}
---------------------------------------

HPLC-grade acetonitrile, methanol and water were obtained from Merck (Darmstadt, Germany). Formic acid was purchased from Sigma-Aldrich (St. Louis, MO, USA). Standard compounds were isolated and purified from *Platycodon grandiflorum* roots by a series of chromatography procedures in our laboratory, and their structures were elucidated by a comparison of the spectroscopic data (MS, ^1^H-NMR and ^13^C-NMR) with the literature data: platycoside E \[[@B25-ijms-16-25993]\], platycodin D3 \[[@B26-ijms-16-25993]\], platycodin D \[[@B27-ijms-16-25993]\], platycodin D2 \[[@B26-ijms-16-25993]\], polygalacin D \[[@B26-ijms-16-25993]\], platycogenic acid A \[[@B2-ijms-16-25993]\] and platycodigenin \[[@B28-ijms-16-25993]\]. The purity of the isolated compounds was determined to be more than 98% by normalization of the peak areas detected by HPLC analysis.

3.3. Sample Preparation {#sec3dot3-ijms-16-25993}
-----------------------

Each sample was dried at 40 °C in a forced-air convection-drying oven for 48 h after washing, and then weighed. The main and lateral roots were used in experiments after removing the rhizomes and fine roots. The roots were ground (\<0.5 mm) using a mixer (Hanil, Seoul, Korea) and thoroughly mixed, after which the subsamples were homogenized further using a Retsch MM400 mixer mill (Retsch GmbH, Haan, Germany) for the analyses. Fine powder was weighed (50 mg), suspended in 40 mL of 70% (*v*/*v*) ethanol and ultrasonically extracted for 1 h at 50 °C. The extract was filtered and evaporated by using a solvent evaporator, Genevac Ez-2 (Genevac Ltd, Suffolk, UK), and the residue (5 mg) was dissolved in the 1 mL of 70% methanol. The solution was filtered through a syringe filter (0.22 µm) and injected directly into the UPLC system.

3.4. UPLC-QTOF-MS Analysis {#sec3dot4-ijms-16-25993}
--------------------------

UPLC was performed using a Waters ACQUITY H-Class UPLC (Waters Corp, Milford, MA, USA). Chromatographic separations were performed on an ACQUITY BEH C18 column (2.1 mm × 100 mm, 1.7 µm). The column oven was maintained at 40 °C, and the mobile phases consisted of Solvent A (5% acetonitrile + 0.1% formic acid (*v*/*v*)) and Solvent B (95% acetonitrile + 0.1% formic acid (*v*/*v*)). The flow rate was 450 μL/min, and the injection volume was 2 μL for each run. Next, MS analysis was performed using a Waters Xevo G2-S QTOF MS (Waters Corp.) operating in positive and negative ion mode. The mass spectrometers performed alternative high- and low-energy scans, known as the MS^E^ acquisition mode. The operating parameters were set as follows: cone voltage, 40 V; capillary, 3.0 kV; source temperature, 120 °C; desolvation temperature, 300 °C; cone gas flow, 30 L/h; and desolvation gas flow, 600 L/h. Accurate mass measurements were obtained by means of an automated calibration delivery system, which contains the internal reference (Leucine, *m/z* 556.276 (ESI+), *m/z* 554.262(ESI-)). Data were collected between 100 and 2000 *m/z*. In the quantitative analysis of each metabolite, the height of peaks was used to measure the intensity.

4. Conclusions {#sec4-ijms-16-25993}
==============

A profiling method based on UPLC-QTOF/MS was developed to analyze various metabolites contained in *P. grandiflorum*. UPLC separation conditions were optimized by using seven isolated compounds. The protocols for extracting *P. grandiflorum* metabolites were optimized as follows: solvent used, 70% EtOH; the ratio of solvent to sample, 40 mL:50 mg; and sonication time, 60 min. We applied this method to profile two different parts of *P. grandiflorum* (PR and PS), in what was a first attempt to characterize various metabolites in PR and PS, respectively. In the negative ion modes, PR and PS showed qualitatively and quantitatively different metabolite profiles. The metabolite compositions also differed according to the each species. These results indicated that the UPLC-QTOF/MS-based profiling method has potential as a tool to analyze various metabolites in *P. grandiflorum*. Hence, this study is of great significance regarding evaluations of the overall quality of *P. grandiflorum* in pharmacological and clinical investigations of drug products. Furthermore, this metabolomics approach could be applied to discriminate cultivars for use in the agricultural and pharmacological industries.

This work was carried out with the support of the "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ01035103)", Rural Development Administration, Republic of Korea.

Dae-Young Lee conceived and supervised the study. Jae Won Lee, Seung-Heon Ji, Yurry Um, Ok Tae Kim, Chang Pyo Hong, Dong-Ho Shin, Chang-Kug Kim, and Seung-Eun Lee performed the study. Kyung-Sik Song provided compounds. Geum-Soog Kim, Yi Lee, and Young-Sup Ahn analyzed the results. Jae Won Lee and Dae-Young Lee wrote the manuscript. All authors corrected the manuscript.

The authors declare no conflict of interest.
